Recombinant soluble thrombomodulin attenuates cisplatin-induced intestinal injury by inhibiting intestinal epithelial cell-derived cytokine secretion.
Takanori YamaguchiArong GaowaEun Jeong ParkIsao TawaraMotomu ShimaokaPublished in: Molecular biology reports (2023)
rsTM suppresses cisplatin-induced intestinal epithelial cell-derived cytokine production and alleviates intestinal mucositis.
Keyphrases